The Mucopolysaccharidosis II Market size is expected to grow at an annual average of 5% during 2022-2028. Mucopolysaccharide II (MPS II)/Hunter syndrome is a congenital disorder that causes complications in carbohydrate metabolism. The first individual with X-linked mucopolysaccharidosis (MPS) was first reported in 1917 by a clinician named Hunter. Hunter syndrome is known to occur […]
